Health

E121: Obinutuzumab in SLE-LN

The Evidence Based Rheumatology Podcast by Michael Putman

Apr 2, 202518:14Health

Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found her...

About This Episode

E121: Obinutuzumab in SLE-LN is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20...

Podcast

This episode belongs to The Evidence Based Rheumatology Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Apr 2, 2025, 18:14 long, audio available.

E121: Obinutuzumab in SLE-LN

About This Episode

Related Episodes